Selecta Biosciences, Inc.
SELB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $103,505 | $103,403 | $163,577 | $372,712 |
| - Cash | $212,610 | $76,911 | $106,438 | $114,057 |
| + Debt | $13,984 | $10,955 | $37,925 | $35,281 |
| Enterprise Value | -$95,121 | $37,447 | $95,064 | $293,936 |
| Revenue | $38,913 | $0 | $110,777 | $85,077 |
| % Growth | – | -100% | 30.2% | – |
| Gross Profit | $0 | $0 | $38,400 | $16,341 |
| % Margin | 0% | – | 34.7% | 19.2% |
| EBITDA | $0 | -$240,779 | $16,155 | -$6,862 |
| % Margin | 0% | – | 14.6% | -8.1% |
| Net Income | -$77,424 | -$219,710 | $35,379 | -$25,687 |
| % Margin | -199% | – | 31.9% | -30.2% |
| EPS Diluted | -0.5 | -1.42 | 0.24 | -0.22 |
| % Growth | 64.8% | -691.7% | 209.1% | – |
| Operating Cash Flow | -$23,674 | -$51,161 | -$31,631 | -$60,382 |
| Capital Expenditures | -$9,093 | -$206 | -$1,201 | -$1,085 |
| Free Cash Flow | -$32,767 | -$51,367 | -$32,832 | -$61,467 |